|
Mar. 15, 2019 |
|
|
Dec. 31, 2022 |
|
|
jRCTs032180286 |
Robotic assisted pyeloplasty using da Vinci Surgical system Si/Xi for ureteropelvic junction stenosis in children. |
|
Robotic assisted pyeloplasty in children. |
|
Jan. 18, 2021 |
|
7 |
|
Mean age at surgery was 7.4 years old (range 3-10). Ureteropelvic junction obstruction is 6 left and 1 right. Robotic-assisted pyeloplasty was performed |
|
7 patients at our institution were registered into this study |
|
There were no adverse events in this study |
|
< Primary endpoint > There were no adverse events. < Secondary endpoint > Mean operative time and Mean blood loss were 368 min (range 243-516) and 6 mL (range 1-15), respectively. Duration of hospital stay was mean 7 days (range 1-15) |
|
Robotic-assisted pyeloplasty can be performed safely and successfully without any adverse events |
|
Dec. 31, 2022 |
Yes |
|
Results on the robotic-assisted pyeloplasty plan to present on pediatric surgical meetings and publish on medical journal. These never include personal identifiable data. |
|
https://jrct.mhlw.go.jp/latest-detail/jRCTs032180286 |
Yamataka Atsuyuki |
||
Juntendo University Hospital |
||
3-1-3 Hongo, Bunkyo-ku, Tokyo |
||
+81-3-3813-3111 |
||
yama@juntendo.ac.jp |
||
Murakami Hiroshi |
||
Juntendo University Hospital |
||
3-1-3 Hongo, Bunkyo-ku, Tokyo |
||
+81-3-3813-3111 |
||
hmuraka@juntendo.ac.jp |
Complete |
Aug. 31, 2017 |
||
| Nov. 21, 2018 | ||
| 40 | ||
Interventional |
||
non-randomized controlled trial |
||
open(masking not used) |
||
active control |
||
parallel assignment |
||
treatment purpose |
||
Juntendo University Medical School Association Juntendo Medical Institute Pediatric Surgery / Childhood Urology and Orthopedic Surgery Pelvic ureteral transitional stenosis patients with surgery indications visited or hospitalized |
||
Patient who the researcher judged inappropriate as the subject |
||
| 1age old over | ||
| 15age old under | ||
Both |
||
Ureteropelvic part stenosis |
||
Use the da Vinci Surgical system when performing renal pelvic formation. |
||
Adverse event occurrence rate: At the time of approach, consider whether there is complication after intraoperative or postoperative. Transition to laparotomy or laparoscopic surgery, blood transfusion practice, organ damage, vascular injury, postoperative bleeding, postoperative infection, pulmonary infarction, gas embolism |
||
1) Surgical results: operation time, bleeding volume |
||
| Juntendo Hospital Certified Review Board | |
| 3-1-3,Hongo,Bunkyo-ku,Tokyo 113-8431, Tokyo | |
+81-3-5802-1584 |
|
| crbjun@juntendo.ac.jp | |
| Approval | |
Mar. 05, 2019 |
| UMIN000035800 | |
| University hospital Medical Information Network Center (UMIN) |
none |